Casdin Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-310,000
Closed -$8.88M 44
2023
Q1
$8.88M Buy
310,000
+145,000
+88% +$4.15M 0.73% 31
2022
Q4
$5.15M Buy
+165,000
New +$5.15M 0.4% 34